Literature DB >> 17075613

Clinical features of muscle dysmorphia among males with body dysmorphic disorder.

Courtney G Pope, Harrison G Pope, William Menard, Christina Fay, Roberto Olivardia, Katharine A Phillips.   

Abstract

Muscle dysmorphia - a pathological preoccupation with muscularity - appears to be a form of body dysmorphic disorder (BDD) with a focus on muscularity. However, little is known about muscle dysmorphia in men with BDD, and no study has compared men with BDD who do and do not report muscle dysmorphia. To explore this issue, we reviewed the histories of 63 men with BDD; we compared those rated as having a history of muscle dysmorphia with those who had BDD but not muscle dysmorphia in several domains. The 14 men with muscle dysmorphia resembled the 49 comparison men in demographic features, BDD severity, delusionality, and number of non-muscle-related body parts of concern. However, those with muscle dysmorphia were more likely to have attempted suicide, had poorer quality of life, and had a higher frequency of any substance use disorder and anabolic steroid abuse. Thus, muscle dysmorphia was associated with greater psychopathology.

Entities:  

Year:  2005        PMID: 17075613      PMCID: PMC1627897          DOI: 10.1016/j.bodyim.2005.09.001

Source DB:  PubMed          Journal:  Body Image        ISSN: 1740-1445


  20 in total

1.  Obsessive-compulsive disorder and comorbid anxiety problems in a national anxiety screening sample.

Authors:  L A Welkowitz; E L Struening; J Pittman; M Guardino; J Welkowitz
Journal:  J Anxiety Disord       Date:  2000 Sep-Oct

2.  Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach.

Authors:  Katharine A Phillips
Journal:  CNS Spectr       Date:  2002-06       Impact factor: 3.790

3.  Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard; Christina Fay; Risa Weisberg
Journal:  Psychosomatics       Date:  2005 Jul-Aug       Impact factor: 2.386

4.  Muscle dysmorphia.

Authors:  K A Phillips; R L O'Sullivan; H G Pope
Journal:  J Clin Psychiatry       Date:  1997-08       Impact factor: 4.384

Review 5.  The influence of comorbidity on the prevalence of suicidal behaviour.

Authors:  Y Lecrubier
Journal:  Eur Psychiatry       Date:  2001-11       Impact factor: 5.361

6.  Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders.

Authors:  H G Pope; D L Katz; J I Hudson
Journal:  Compr Psychiatry       Date:  1993 Nov-Dec       Impact factor: 3.735

7.  Muscle dysmorphia. An underrecognized form of body dysmorphic disorder.

Authors:  H G Pope; A J Gruber; P Choi; R Olivardia; K A Phillips
Journal:  Psychosomatics       Date:  1997 Nov-Dec       Impact factor: 2.386

8.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

Review 9.  Muscle dysmorphia: a critical review of the proposed criteria.

Authors:  B Chung
Journal:  Perspect Biol Med       Date:  2001       Impact factor: 1.416

10.  Anabolic steroid users' attitudes towards physicians.

Authors:  Harrison G Pope; Gen Kanayama; Martin Ionescu-Pioggia; James I Hudson
Journal:  Addiction       Date:  2004-09       Impact factor: 6.526

View more
  30 in total

Review 1.  Body dysmorphic disorder: some key issues for DSM-V.

Authors:  Katharine A Phillips; Sabine Wilhelm; Lorrin M Koran; Elizabeth R Didie; Brian A Fallon; Jamie Feusner; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 2.  Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.

Authors:  Eberhard Nieschlag; Elena Vorona
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 3.  Vitamin D: recent advances and implications for athletes.

Authors:  Joshua J Todd; L Kirsty Pourshahidi; Emeir M McSorley; Sharon M Madigan; Pamela J Magee
Journal:  Sports Med       Date:  2015-02       Impact factor: 11.136

Review 4.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

5.  Modular cognitive-behavioral therapy for body dysmorphic disorder.

Authors:  Sabine Wilhelm; Katharine A Phillips; Jeanne M Fama; Jennifer L Greenberg; Gail Steketee
Journal:  Behav Ther       Date:  2011-05-01

6.  Body image disturbance in 1000 male appearance and performance enhancing drug users.

Authors:  Tom Hildebrandt; Lauren Alfano; James W Langenbucher
Journal:  J Psychiatr Res       Date:  2010-01-27       Impact factor: 4.791

7.  The Presentation of Body Dysmorphic Disorder in Medical Settings.

Authors:  Katharine A Phillips
Journal:  Prim psychiatry       Date:  2006-07

8.  Body Image Distortions, Weight, and Depression in Adolescent Boys: Longitudinal Trajectories into Adulthood.

Authors:  Aaron J Blashill; Sabine Wilhelm
Journal:  Psychol Men Masc       Date:  2014

Review 9.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 10.  Anabolic-androgenic steroid dependence: an emerging disorder.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Addiction       Date:  2009-12       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.